Opioid Taper Study

CompletedOBSERVATIONAL
Enrollment

7

Participants

Timeline

Start Date

April 15, 2019

Primary Completion Date

May 31, 2021

Study Completion Date

May 31, 2021

Conditions
Chronic Pain
Interventions
OTHER

Opioid Taper Pain perception

Pain Responses: The primary dependent variable, pain, will be measured using two highly reliable and valid pain induction techniques, the CPT and QST, employing procedures consistent with those described in the literature. Order of pain testing will vary, and three aspects of the pain response will be captured at each study session: evoked pain; temporal summation; and conditioned pain modulation, which map on to the hypothesized peripheral, spinal and supra-spinal mechanisms of OIH. Protocols for each assay have been uploaded.

Trial Locations (1)

19146

Penn Pain Medicine Center Tuttleman Center, Philadelphia

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

National Institutes of Health (NIH)

NIH

lead

University of Pennsylvania

OTHER

NCT03912298 - Opioid Taper Study | Biotech Hunter | Biotech Hunter